Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region
Open Access
- 29 November 2022
- journal article
- review article
- Published by Springer Nature in Dermatology and Therapy
- Vol. 13 (1) , 131-146
Abstract
Introduction Atopic dermatitis (AD) is a chronic skin disease that poses a significant burden on both patients and the society. AD causes the highest loss in disability-adjusted life years compared with other skin diseases. This study aimed to estimate the economic and humanistic burden of AD in adults and adolescents in seven countries in the Middle East and Africa region (Egypt, Lebanon, Saudi Arabia, Kuwait, Algeria, South Africa, and United Arab Emirates). Methods We conducted a literature review to identify country-specific data on this disease. Subsequently, meetings were organized with experts from each country to complete the missing data. The data were aggregated and calculation models were created to estimate the value of the humanistic and economic burden of the disease in each country. Finally, we conducted meetings with local experts to validate the results, and the necessary adjustments were made. Results On average, a patient with AD loses 0.19 quality-adjusted life years (QALYs) annually owing to this disease. The average annual healthcare cost per patient is highest in the United Arab Emirates, with an estimated value of US $3569 and a population-level indirect cost of US $112.5 million. The included countries allocated a range of 0.20–0.77% of their healthcare expenditure to AD-related healthcare services and technologies. The indirect cost of AD represents approximately 67% of the total disease cost and, on average, approximately 0.043% (range 0.022–0.059%) of the gross domestic product (GDP) of each country. Conclusion Although the humanistic and economic burdens differ from country to country, AD carries a significant socioeconomic burden in all countries. The quality of life is severely affected by the disease. If AD is controlled, the costs, especially indirect costs, could decrease and the disease burden could be alleviated significantly.Keywords
Funding Information
- AbbVie
This publication has 24 references indexed in Scilit:
- Impact of Weather Conditions on Atopic Dermatitis Prevalence in Abuja, NigeriaJournal of the National Medical Association, 2019
- Patient burden and quality of life in atopic dermatitis in US adultsAnnals of Allergy, Asthma & Immunology, 2018
- Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countriesThe European Journal of Health Economics, 2018
- Epidemiology of atopic dermatitis in adults: Results from an international surveyAllergy, 2018
- Psychological Health Status and Health-related Quality of Life in Adults with Atopic Dermatitis: A Nationwide Cross-sectional Study in South KoreaActa Dermato-Venereologica, 2018
- Willingness to pay and quality of life in patients with atopic dermatitisArchives of Dermatological Research, 2013
- Climatic Factors Are Associated with Childhood Eczema Prevalence in the United StatesJournal of Investigative Dermatology, 2013
- Measuring Health-Related Productivity LossPopulation Health Management, 2011
- A Population-Based Survey of Eczema Prevalence in the United StatesDermatitis®, 2007
- Health and Disability Costs of Depressive Illness in a Major U.S. CorporationAmerican Journal of Psychiatry, 2000